Angel Aid Cares’ Rare Mother Meetup

  • Post author:
  • Post category:

Rare Mother Meetup 6:00 PM, PST The Rare Mother Meetup will take place on the second Wednesday of each month and is hosted by Rare Mother Ashley Kenny. The meetup…

Continue Reading Angel Aid Cares’ Rare Mother Meetup
FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer
source: pixabay.com

FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer

FoundationOne CDx is a comprehensive genomic profiling test that is tissue based. It is used to identify individuals diagnosed with ALK+ non-small-cell lung cancer (NSCLC) who will be eligible for…

Continue Reading FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer
August is Stevens-Johnson Syndrome Awareness Month: Spreading Rare Disease Awareness
source: pixabay,com

August is Stevens-Johnson Syndrome Awareness Month: Spreading Rare Disease Awareness

The month of August is recognized as Stevens-Johnson Syndrome Awareness Month. The goal of this event is to elevate awareness about Stevens-Johnson syndrome among the general public and in the…

Continue Reading August is Stevens-Johnson Syndrome Awareness Month: Spreading Rare Disease Awareness

Angel Aid Cares’ Rare Mother Meetup

  • Post author:
  • Post category:

Rare Mother Meetup 6:00 PM, PST The Rare Mother Meetup will take place on the second Wednesday of each month and is hosted by Rare Mother Ashley Kenny. The meetup…

Continue Reading Angel Aid Cares’ Rare Mother Meetup
NYUAD Researchers Identify the Code That Regulates Liver Regrowth: A New Form of Regenerative Medicine May Follow
source: pixabay.com

NYUAD Researchers Identify the Code That Regulates Liver Regrowth: A New Form of Regenerative Medicine May Follow

  Researchers at NYU Abu Dhabi (NYUAD) have discovered the code that is associated with the liver’s genome (complete set of DNA) and its ability to regenerate. According to a…

Continue Reading NYUAD Researchers Identify the Code That Regulates Liver Regrowth: A New Form of Regenerative Medicine May Follow
Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy
source: pixabay.com

Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy

Aurinia Pharmaceuticals has just announced that Otsuka Pharmaceutical Europe Ltd. (OPEL), their licensing partner, has just filed a Marketing Authorization Application for an investigative therapy for lupus nephritis (LN) called…

Continue Reading Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy

Cambridge Rare Disease Network’s RAREsummit21

  • Post author:
  • Post category:

RAREsummit21 October 7, 2021 CRDN's RAREsummit21 is designed as a platform for change. This is an opportunity to hear from and engage with the stakeholders that are creating change across…

Continue Reading Cambridge Rare Disease Network’s RAREsummit21